Neuropathic Pain Management

Phase 3 Completed 104 enrolled Merck KGaA, Darmstadt, Germany Merck S.A. de C.V., Mexico · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a prospective, randomized, double blind, comparative, experimental controlled Phase 3 clinical trial to assess the efficacy, safety and superiority of F0343 (gabapentin combined with B vitamins) compared to gabapentin alone for treating neuropathic pain in subjects with chronic distal diabetic polyneuropathy.

Timeline

Start: 2008-02
Primary completion: 2010-02
Completion: 2010-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	F0434	Unknown	—	Oral
Comparator	Gabapentin	Small molecule	—	Oral

Neuropathic Pain Management

Summary

Timeline

Drugs

Indications